Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Eila Skinner MD

Eila C. Skinner MD

Thomas A. Stamey Research Professor of Urology, Stanford University School of Medicine, Stanford, California

Dr. Skinner is the Chair of the Department of Urology at Stanford University and the Thomas A. Stamey Research Professor of Urology. She obtained her urologic training at Los Angeles County Hospital/USC School of Medicine and completed a fellowship in urologic oncology under Dr. Donald Skinner at USC Norris Comprehensive Cancer Center. She was on the faculty at USC from 1990 through 2012 when she was recruited to Stanford. Dr. Skinner’s research and clinical practice are focused on focused on refining treatments for high-risk non-muscle invasive and invasive bladder cancer, and urinary tract reconstruction with continent urinary diversion

Recent Contributions to PracticeUpdate:

  1. Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder
  2. Ureteral Stent at Radical Cystectomy Is Associated With Higher 30-Day Complication Rates
  3. Early Continence After Ileal Neobladder
  4. Pelvic Exenteration Surgery in Patients With Locally Advanced Prostate Cancer
  5. Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy
  6. Risk of Ovarian Malignancy in Patients Undergoing Radical Cystectomy for Bladder Cancer
  7. High Rates of Upstaging in Patients With T1 High-Grade Bladder Cancer
  8. Defining Progression in Nonmuscle Invasive Bladder Cancer

Recently Updated